title: Studies on the mechanism of accumulation of cholesterol in the gallbladder mucosa. Evidence that sterol 27-hydroxylase is not a pathogenetic factor.
abstract: OBJECTIVE
  Cholesterolosis is characterized by accumulation of esterified cholesterol in human gallbladder mucosa. The present study aimed at investigating possible pathogenetic factors for cholesterolosis. The hypothesis was tested that a reduced sterol 27-hydroxylase or an increased amount of ACAT-1 enzyme may be of importance.
  
  
  METHODS
  Gall bladder mucosa and bile were obtained from patients with cholesterol gallstones undergoing cholecystectomy (30 with and 43 without cholesterolosis).
  
  
  RESULTS
  In cholesterolosis, the gall bladder mucosa was characterized by a several-fold increase in esterified cholesterol and normal content of free cholesterol. The amount of ACAT-1 protein, measured by immunoblotting, was similar in patients with and without cholesterolosis. The level of 27-hydroxycholesterol in gallbladder mucosa was elevated sevenfold as compared with cholesterol in patients with cholesterolosis. Most (87%) of this oxysterol was esterified and the accumulation is most probably secondary to the higher total amount of cholesterol in the cells. Patients with cholesterolosis had normal levels of both sterol 27-hydroxylase mRNA (real time polymerase chain reaction) and protein (immunoblotting). The enzymatic activity of the sterol 27-hydroxylase in gallbladder mucosa was normal or increased in cholesterolosis.
  
  
  CONCLUSIONS
  The pathogenesis of cholesterolosis may be multifactorial, but is not caused by reduced efflux of cholesterol due to a defect sterol 27-hydroxylase mechanism.
authors.affiliation: Division of Clinical Chemistry, Department of Laboratory Medicine, Huddinge University Hospital, K63, SE-141 86 Stockholm, Sweden.
authors.forename: Anna
authors.initials: A
authors.lastname: Strömsten
authors.forename: Sara
authors.initials: S
authors.lastname: von Bahr
authors.forename: Sven
authors.initials: S
authors.lastname: Bringman
authors.forename: Masayumi
authors.initials: M
authors.lastname: Saeki
authors.forename: Staffan
authors.initials: S
authors.lastname: Sahlin
authors.forename: Ingemar
authors.initials: I
authors.lastname: Björkhem
authors.forename: Curt
authors.initials: C
authors.lastname: Einarsson
mesh_terms: D001646:Bile / Q000737:chemistry; D053493:Cholestanetriol 26-Monooxygenase; D002784:Cholesterol / Q000032:analysis / Q000378:metabolism*; D004951:Esterification; D005260:Female; D005704:Gallbladder / Q000201:enzymology / Q000378:metabolism*; D005705:Gallbladder Diseases / Q000201:enzymology / Q000209:etiology* / Q000378:metabolism; D006801:Humans; D008055:Lipids / Q000032:analysis; D008297:Male; D008875:Middle Aged; D009092:Mucous Membrane / Q000737:chemistry / Q000201:enzymology / Q000378:metabolism*; D012333:RNA, Messenger / Q000032:analysis; D013250:Steroid Hydroxylases / Q000032:analysis / Q000235:genetics / Q000378:metabolism*; D002785:Sterol O-Acyltransferase / Q000032:analysis / Q000235:genetics / Q000378:metabolism
chemical_list: D008055:Lipids; D012333:RNA, Messenger; D002784:Cholesterol; D013250:Steroid Hydroxylases; C506831:CYP27A1 protein, human; D053493:Cholestanetriol 26-Monooxygenase; D002785:Sterol O-Acyltransferase